Coldstream Capital Management Inc Roivant Sciences Ltd. Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
321Shares Held
502MCall Options Held
460KPut Options Held
723K-
Qvt Financial LP New York, NY65.8MShares$761 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$716 Million5.69% of portfolio
-
Viking Global Investors LP47.8MShares$553 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$472 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$416 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...